Search Results - "Barfield, M."

Refine Results
  1. 1

    Synthesis of Heterobifunctional Protein Fusions Using Copper-Free Click Chemistry and the Aldehyde Tag by Hudak, Jason E., Barfield, Robyn M., de Hart, Gregory W., Grob, Patricia, Nogales, Eva, Bertozzi, Carolyn R., Rabuka, David

    Published in Angewandte Chemie (International ed.) (23-04-2012)
    “…Clicking into place: Cu‐free click chemistry is combined with the aldehyde tag protein modification strategy to produce heterobifunctional protein fusions…”
    Get full text
    Journal Article
  2. 2

    Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell death selectively in antigen-positive target cells by Bauzon, Maxine, Drake, Penelope M, Barfield, Robyn M, Cornali, Brandon M, Rupniewski, Igor, Rabuka, David

    Published in Oncoimmunology (01-01-2019)
    “…Oncology treatment has been revolutionized by the introduction of immune checkpoint inhibitor drugs, which enable 20-40% of patients to generate anti-tumor…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The phenomenology of niche evolution via quantitative traits in a ‘black-hole’ sink by Holt, R. D., Gomulkiewicz, R., Barfield, M.

    “…Previous studies of adaptive evolution in sink habitats (in which isolated populations of a species cannot persist deterministically) have highlighted the…”
    Get full text
    Journal Article
  5. 5

    Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer by Harel, Efrat T, Drake, Penelope M, Barfield, Robyn M, Lui, Irene, Farr-Jones, Shauna, Van't Veer, Laura, Gartner, Zev J, Green, Evan M, Lourenço, André Luiz, Cheng, Yifan, Hann, Byron C, Rabuka, David, Craik, Charles S

    Published in Antibodies (Basel) (05-11-2019)
    “…A promising molecular target for aggressive cancers is the urokinase receptor (uPAR). A fully human, recombinant antibody that binds uPAR to form a stable…”
    Get full text
    Journal Article
  6. 6

    Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations by Spooner, Neil, Ramakrishnan, Y, Barfield, M, Dewit, O, Miller, S

    Published in Bioanalysis (01-08-2010)
    “…A clinical investigation was performed into the practicalities of the collection of blood samples for the determination of drug exposures on filter paper,…”
    Get more information
    Journal Article
  7. 7

    Effects of Compost on the Chemistry of an Urban Upper Piedmont South Carolina Soil by Mikhailova, E. A., Schlautman, M. A., Darnault, C. J. G., Sharp, J. L., Post, C. J., Hall, K. C., Ouzts, E. V., Barfield, M. A.

    “…Composting is an effective method to improve the fertility of degraded soils. However, the potential beneficial effects of composting on the fertility of urban…”
    Get full text
    Journal Article
  8. 8

    Systematic LC/MS/MS Investigations for the IND-Enabling Extended Characterization of Antibody–Drug Conjugate Modifications by Linz, Thomas, Yeo, Dominick, Hong, Qiuting, Zmolek, Wesley, McFarland, Jesse, Barfield, Robyn, Haskins, William, Rabuka, David

    Published in Antibodies (Basel) (01-12-2018)
    “…We hypothesized that systematic liquid chromatography-tandem mass spectrometry investigations of an antibody–drug conjugate (ADC), its small and large…”
    Get full text
    Journal Article
  9. 9

    A DFT Study of the Interresidue Dependencies of Scalar J-Coupling and Magnetic Shielding in the Hydrogen-Bonding Regions of a DNA Triplex by Barfield, Michael, Dingley, Andrew J, Feigon, Juli, Grzesiek, Stephan

    Published in Journal of the American Chemical Society (02-05-2001)
    “…Scalar coupling constants and magnetic shieldings in the imino hydrogen-bonding region of Hoogsteen−Watson−Crick T·A-T and C+·G−C triplets have been calculated…”
    Get full text
    Journal Article
  10. 10

    Leveraging Formylglycine-Generating Enzyme for Production of Site-Specifically Modified Bioconjugates by Barfield, Robyn M, Rabuka, David

    “…Enzymatic modification of proteins can generate uniquely reactive chemical functionality, enabling site-specific reactions on the protein surface…”
    Get more information
    Journal Article
  11. 11

    Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody–Drug Conjugates by Chuprakov, Stepan, Ogunkoya, Ayodele O, Barfield, Robyn M, Bauzon, Maxine, Hickle, Colin, Kim, Yun Cheol, Yeo, Dominick, Zhang, Fangjiu, Rabuka, David, Drake, Penelope M

    Published in Bioconjugate chemistry (21-04-2021)
    “…Although peptide motifs represent the majority of cleavable linkers used in clinical-stage antibody–drug conjugates (ADCs), the sequences are often sensitive…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Site-Specific Bioconjugation Using SMARTag ® Technology: A Practical and Effective Chemoenzymatic Approach to Generate Antibody-Drug Conjugates by Liu, Junjie, Barfield, Robyn M, Rabuka, David

    “…As a critical feature of the next generation of antibody-drug conjugates (ADCs), site-specific bioconjugation approaches can help to optimize stability,…”
    Get more information
    Journal Article
  14. 14

    Multiple acquired portosystemic shunts in a cat secondary to chronic diaphragmatic rupture by Barfield, Dominic M, Gibson, Andrew D, Lipscomb, Vicky J

    Published in JFMS open reports (2015)
    “…A cat with a chronic diaphragmatic rupture presented with neurological signs, including twitching and focal seizures. Blood ammonia level was markedly elevated…”
    Get full text
    Journal Article
  15. 15

    Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates by Agarwal, Paresh, Kudirka, Romas, Albers, Aaron E, Barfield, Robyn M, de Hart, Gregory W, Drake, Penelope M, Jones, Lesley C, Rabuka, David

    Published in Bioconjugate chemistry (19-06-2013)
    “…Aldehyde- and ketone-functionalized biomolecules have found widespread use in biochemical and biotechnological fields. They are typically conjugated with…”
    Get full text
    Journal Article
  16. 16

    CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity by Tsui, C. Kimberly, Barfield, Robyn M., Fischer, Curt R., Morgens, David W., Li, Amy, Smith, Benjamin A. H., Gray, Melissa Anne, Bertozzi, Carolyn R., Rabuka, David, Bassik, Michael C.

    Published in Nature chemical biology (01-10-2019)
    “…Antibody–drug conjugates (ADCs) selectively deliver chemotherapeutic agents to target cells and are important cancer therapeutics. However, the mechanisms by…”
    Get full text
    Journal Article
  17. 17

    Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion by Holder, Patrick G., Jones, Lesley C., Drake, Penelope M., Barfield, Robyn M., Bañas, Stefanie, de Hart, Gregory W., Baker, Jeanne, Rabuka, David

    Published in The Journal of biological chemistry (19-06-2015)
    “…To further our aim of synthesizing aldehyde-tagged proteins for research and biotechnology applications, we developed methods for recombinant production of…”
    Get full text
    Journal Article
  18. 18

    A Novel HER2-targeted Antibody–drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure Levels by Barfield, Robyn M., Kim, Yun Cheol, Chuprakov, Stepan, Zhang, Fangjiu, Bauzon, Maxine, Ogunkoya, Ayodele O., Yeo, Dominick, Hickle, Colin, Pegram, Mark D., Rabuka, David, Drake, Penelope M.

    Published in Molecular cancer therapeutics (01-09-2020)
    “…Abstract Trastuzumab and the related ADC, ado-trastuzumab emtansine (T-DM1), both target HER2-overexpressing cells. Together, these drugs have treatment…”
    Get full text
    Journal Article
  19. 19

    Hydrophilic Sequence-Defined Cross-Linkers for Antibody–Drug Conjugates by Walker, Joshua A, Sorkin, Michelle R, Ledesma, Francis, Kabaria, Sneha R, Barfield, Robyn M, Rabuka, David, Alabi, Christopher A

    Published in Bioconjugate chemistry (20-11-2019)
    “…Antibody–drug conjugates (ADCs) are an established modality for the tissue-specific delivery of chemotherapeutics. However, due to the hydrophobic nature of…”
    Get full text
    Journal Article
  20. 20

    A simple LC/MRM–MS-based method to quantify free linker-payload in antibody-drug conjugate preparations by Zmolek, Wesley, Bañas, Stefanie, Barfield, Robyn M., Rabuka, David, Drake, Penelope M.

    “…•A simple MRM-based method to quantify free linker-payload in an ADC is described.•The approach has an LLOQ of 10nM and requires no special laboratory…”
    Get full text
    Journal Article